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Abstract
The molecularly cloned myeloblastosis-associated virus type-1(N) (MAV-1(N)) strain induces specifically nephroblastomas in chicken.
MAV-induced nephroblastoma constitutes a unique animal model of the human Wilms’ tumor. We have previously shown that the
MAV-1(N) long terminal repeats (LTR) were necessary and sufficient for nephroblastoma induction. Since major determinants for
oncogenesis have been mapped in the U3 region of several other retroviruses, we have analyzed the tumorigenic potential of five
recombinant viruses partially deleted in their U3 region. The results obtained indicated that deletions of the LTRs resulted in a modification
of the pathogenic spectrum of MAV-1(N) and a decreased efficiency for nephroblastoma induction.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Myeloblastosis-associated virus type 1 (MAV-1) is an
avian replicative retrovirus which does not contain an on-
cogene of cellular origin. It is the natural helper of the
defective avian myeloblastosis virus (AMV) which has
transduced a truncated form of c-myb and causes acute
myeloblastic leukemia in chickens (Watts and Smith, 1980).
The molecularly cloned MAV-1(N) exhibited a restricted
pathogenic potential and induced specifically nephroblas-
toma in chicken (Perbal et al., 1985; Soret et al., 1989;
Perbal, 1995).
The characterization of MAV-1(N) as a highly efficient
causative agent for nephroblastoma (Heine, 1962; Ishiguro,
1962,) permitted us to further establish that MAV-induced
tumors constituted an unmatched animal model of the
Wilms’ tumor, a pediatric kidney tumor affecting 1 of
10,000 children (Perbal, 1994). Time course studies of renal
lesions induced by MAV-1(N) established that hyperplasia
of renal cells, reminiscent of human nephroblastomatosis,
was often observed in MAV-1(N)-infected kidneys prior to
nephroblastoma development. At 18 weeks postinjection,
well-developed nephroblastoma is macroscopically ob-
served. The use of chimeric viruses allowed us to establish
that the LTR (long terminal repeat) noncoding sequences of
MAV-1(N) were required for nephroblastoma induction and
that sequences encoding the SU env protein were conferring
on MAV-1(N) its tumorigenic specificity (Joliot et al.,
1996). Our early results suggested that MAV proviral se-
quences were integrated in the vicinity of the CCN3 gene
which encode a member of the CCN family of cell growth
regulators (for a review see Perbal, 2001). More recent
studies have permitted us to establish that the MAV proviral
sequences are integrated in several different chromosomes
in the tumor cell genome and that, except in the case that we
have previously reported (Joliot et al., 1992), they are not
detected in the vicinity of CCN3 in other tumors (Li et al.,
manuscript in preparation).
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The U3 LTR region has been reported to play a critical
role in the pathogenic potential of different retroviruses
(Fan, 1990). For example, replacement of SL3 (T-cell lym-
phomagenic murine leukemia) U3 sequences by FeLV (fe-
line leukemia virus which induces preferentially T-cell lym-
phoma) U3 sequences resulted in a recombinant virus that
could induce T-cell lymphoma nearly as quickly as SL3
when inoculated into mice (Pantginis et al., 1997). Se-
quence analysis of the MAV LTR sequences indicated that
they exhibit a quite specific U3 region (Rushlow et al.,
1982) that might be related to the highly specific pathogenic
potential of this virus. In order to determine whether the U3
region is involved in specifying the restricted pathogenic
potential of MAV-1(N), we have constructed recombinant
viruses in which different stretches of U3 sequences were
deleted. In the present study we have identified three subsets
of LTR U3 sequences whose deletion resulted in a modifi-
cation of the pathogenic spectrum of MAV-1(N) and a
significant decrease in its tumorigenic potential.
Results and discussion
Transcriptional activity and replication rate of the
recombinant viruses
Several potential binding sites for transcription regula-
tors (reviewed in (Ruddell, 1995)) were identified in the
MAV-1(N) U3. An 11-nucleotide direct repeat (located at
positions 34–43 and 59–68) with a CArG box (CC(A/
T)6GG) corresponding to the EFIII (avian serum response
factor) binding site was removed in the 1 and 2 mutants.
Each of three putative Y boxes (GGTTA) corresponding to
EFI binding sites were identified at positions 83–87, 181–
185, and 221–225 within the U3 sequence and were deleted
in the 3, 5, and 6 mutants. Two C/EBP binding sites
localized at positions 22–47 and 33–57 were deleted in both
the 1 and 4 mutants. The C/EBP  protein is expressed
at a high level in the chicken kidney and appears to play an
important role in promoting proliferation (reviewed in
Ramji and Foka, 2002). The position of the deleted se-
quences is indicated in Fig. 1.
In order to determine whether deletions of the U3 se-
quences were affecting LTR-driven transcription, the lucif-
erase reporter was cloned either downstream to the intact
MAV LTR sequences (pMAVLTR-luciferase) or to each of
the LTR deletion mutants (pLTR 1-luc to pLTR6-luc)
(Fig. 2). LTR transcription activity of mutant and wild-type
U3 was assessed in chicken embryo fibroblasts (CEF). The
results obtained (Fig. 2A) indicated that sequences removed
in the MAV1 and MAV3 mutants are essential for MAV
LTR-driven transcription, whereas sequences deleted in
MAV2, 4, 5, and 6 recombinants did not appear to be
required for efficient MAV LTR-driven transcription. We
have now established that blastemal cells committed to
epithelial differentiation constitute MAV target cells in the
kidney of infected chickens (Cherel et al., manuscript in
preparation). Unfortunately, the lack of a cell culture system
amenable to in vitro studies did not permit us to perform
measurements of MAV recombinant transcription and rep-
lication rates in such cells. Preliminary results (data not
shown) indicated that similar transcription rates were also
obtained with infected MDCK (Madin–Darby canine kid-
ney) cells, therefore suggesting that the transcription rates of
Fig. 1. Localization of the regulatory elements and the deletions within the MAV U3 sequence. The U3, R, U5, and leader sequence alignments of MAV-1(N),
MAV-2(O), RAV-1, and PrC RSV are shown (19,10,12,35). Nucleotides are numbered relative to the first nucleotide of the U3 sequence. CAT and TATA
boxes are indicated. The regulatory elements comprising CArG boxes, Y boxes, and C/EBP binding sites are indicated. The U3 delta deletions are shown
as shaded boxes.
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the recombinant MAVs might compare in these different
cell types.
The replication ability of each recombinant MAV strain
was measured ex vivo by measuring reverse transcriptase
activity and compared to that of the wild-type MAV. Inas-
much as all, except MAV5, recombinant viruses gave rise
to progeny at very comparable rates (Fig. 2B), we con-
cluded that sequences deleted in MAV1, 2, 3, 4, and
6 are not required for viral replication in fibroblast cells.
Replication assays performed in CEF are indicative of the
effect of the mutations upon the viral life cycle. Neverthe-
less, our results did not permit us to establish whether the
target cells from which the various tumors arose were
equally infected.
At this point, it is interesting to underline that the 1 and
3 U3 deletions dramatically decreased LTR transcriptional
activity, while the recombinant viruses harboring these mu-
tations showed a replication rate similar to that of the
MAV-1(N). These observations suggested that the viral
context might be of critical importance; cis-acting transcrip-
tional control elements have been localized within the RSV
gag gene (Arrigo et al., 1987) and more recently, it has been
reported that maximal activity of the MMTV superantigen
depends upon the presence of an enhancer within the pol
viral gene (Reuss and Coffin, 1998). Conversely, in the case
of the MAV5 virus, whose LTR shows reasonable tran-
scriptional activity, the lack of progeny production might
result from deficiency in a late step, such as viral packaging.
Pathological properties of MAVX recombinant viruses
in vivo (Table 1)
The MAV recombinants were inoculated intraperitone-
ally at a dose of 3.105 PFU into day-old Brown Leghorn
chickens. Total RNA preparations purified from MAV-
induced nephroblastomas were analyzed for the presence of
mutated LTR sequences by RT–PCR analysis, to ensure that
tumors had not been induced by wild-type MAV-1(N)
Fig. 2. (A) Transcriptional activity of the mutated MAV LTR. CEF cells were transfected with 2 g of the various reporter plasmids and assayed for luciferase
activity. Nine independent experiments were performed and the average of the results is represented. For some experiments, cotransfection with the
pAct--Gal plasmid indicated that transfection efficiencies were comparable. (B) Reverse transcriptase activity of MAVx-infected CEF supernatants; 5 
105 CEF cells were infected with 5  106 PFU of the MAV1, MAV2, MAV3, MAV4, and MAV6 mutant viruses. Supernatants were tested for their
RT activity every day for 8 days. RT values per volume of supernatant were normalized to the value of the positive control for the test. The RT curves
represent the average of two independent experiments.
Table 1
Pathogenic potential of MAV mutant viruses
Viruses No. of
animals
No. of dysplastic
lesions (%)
No. of
nephroblastomas (%)
No. of
leukosis cases (%)
Other
pathologies
MAV1 20 2 (10%) 8 (40%) 1 (5%) 0
MAV2 24 10 (42%) 14 (58%) 0 (0%) 2 (UN)a
MAV3 17 5 (29%) 6 (35%) 1 (6%) 1 (UN)
MAV4 15 1 (9%) 7 (47%) 2 (13%) 1 (UN)
MAV6 19 7 (15%) 15 (79%) 0 (0) 0
MAV-1(N) 51 None 51 (100%) None None
a UN, unknown cause of death.
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present in the recombinant MAV stocks or rescued in vivo
(data not shown).
The MAV2 and MAV6 recombinant viruses exhib-
ited a pathogenic potential close to that of MAV-1(N). The
high incidence of nephroblastomas obtained for both strains
(58% for MAV2 and 79% for MAV6) indicated that
LTR sequences deleted in MAV2 and MAV6 were not
required for a high efficiency of tumor induction. Con-
versely, the rates of nephroblastoma induction observed
with the MAV1, MAV3, and MAV4 recombinants (40,
35, and 47%, respectively) indicated that determinants of
tumor induction were contained in the deleted U3 sequences
(2 tests, significant differences between 1 and 6 (P 
0.03), 3 and 6 (P  0.02), 4 and 6 (P  0.05), and no
difference between 2 and 6). The fact that none of the
deletions totally inhibited the tumorigenic potential of the
virus might be related to the particularly high efficiency of
MAV-1(N) in inducing nephroblastoma (Soret et al., 1989).
Fig. 3. Histological analysis of tumors induced by recombinant MAV strains. (Panel 1). Severe hyperplasia associated with some inflammatory cells (arrow
bar). The poorly differentiated tubules show basophilic staining; bar, 200 m. (Panel 2). (Dysplastic figures) The dilated and dysplatic tubules are associated
with proliferating connective tissue; bar, 400 m. (Panel 3) (Nephroblastoma) Nests of tubular and trabecular epithelial tumoral cells are mixed with
proliferative stomal sheets. Some of these areas are made of cartilaginous ( ) and squamous (Š) metaplasia; bar, 400 m. (Panel 4) (Malignant lymphoma
(leukosis)) The kidney is totally innvaded by tumoral lymphoid cells extending throughout the kidney structures. Only very few renal tubules are recognizable
(arrow) surrounded by tumoral cells (bar, 200 m).
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While the MAV2 and MAV6 recombinants only in-
duced kidney cancers, the MAV1, 3, and 4 strains
induced a statistically significant amount of lymphoid leu-
cosis, in addition to nephroblastoma. Original studies per-
formed with plaque-purified isolates of several MAV1 and
MAV2 strains reported the induction of leucosis (see review
in Perbal, 1994). In our hands, the molecularly cloned
MAV-1(N) was never found to induce any other tumor than
nephroblastoma by 18 weeks postinfection (Soret et al.,
1989). Therefore, the induction of leucosis by the MAV1,
MAV3, and MAV4 mutant viruses represents a shift in
tumorigenic potential that is associated with a lower inci-
dence of nephroblastoma induction.
This situation is reminiscent of that of murine recombi-
nant retroviruses containing erythroleukemia inducing
Friend murine leukemia virus (F-MuLV) sequences and U3
region from acute myeloid leukemia inducing feline leuke-
mia virus (FeLV) that were previously reported to induce
hematopoietic malignancies, with a significant percentage
(31%) originating from the myeloid lineage (Nishigaki et
al., 2002). In that case, the FeLV U3 region had reoriented
the disease specificity of the F-MuLV virus. Recently, an-
other similar case was provided by the Idefix retrotranspo-
son, whose 5 LTR contains sequences that direct the tissue
specificity expression of retroelements in testes and ovaries
of adult flies (Tcheressiz et al., 2002).
Histological analysis of MAVX-induced nephroblastoma
Histological examination of MAV-induced tumors
(Fig. 3) indicated that nephroblastomas stemed multifocally
from blastemal peripheral nests (with a multicentric origin).
The tumoral tissue was made of the association of epithelial
and connective derivatives, with the epithelial component
containing tubular structures that were often poorly differ-
entiated, with irregular patterns. Some abortive glomeruli
could also be observed. These patterns were associated with
sheets of undifferentiated nephrogenic cells exhibiting no
architectural differentiation. The epithelial sheets were sur-
rounded by a loose clear connective tissue with epithelial
tubules undergoing epidermoid metaplasia. The content of
cartilagenous, bone, and adipous tissue varied greatly
among the different tumors. In the dysplastic lesions the
blastema remained constituted of tubules with irregular pat-
terns, often widely dilated as cystic structures or with epi-
thelial proliferation in their lumen. The epithelium often lost
its usual monolayer structure and exhibited a multistratified
pattern.
Histological examination of the samples established a
viral-induced renal dysplasia in animals injected with re-
combinant viruses (Table 1), while the same analyses per-
formed on control MAV-1(N)-injected animals did not per-
mit us to detect dysplasia during the development of
nephroblastomas. The most significant difference was ob-
served with MAV2 and MAV3, which induced, respec-
tively, 42 and 29% dysplasia. These dysplasic lesions rep-
resent an interesting feature that was not observed for the
MAV-1(N) virus at 18 weeks postinfection.
In humans, defects in renal branching morphogenesis
result in renal dysplasia (Piscione and Rosenblum, 2002).
The study of in vivo models of mouse embryogenesis and
genetic mapping of human syndromes involving malforma-
tions have identified several genes as critical regulators of
the kidney (Piscione and Rosenblum, 2002). The overex-
pression of the CCN3 gene, which was reported to be a
feature of all MAV-induced nephroblastomas (For a review,
see Planque and Perbal, 2003), was also observed in the
tumors induced by the MAV recombinants used in this
study (data not shown).
The genetic events underlying parental and recombinant
MAV-induced dysplasia remain obscure. Virus-induced
dysplasia is often observed especially with papillomavi-
ruses. Early-passage cells from low-grade dysplasia induced
either by human papillomavirus type 16 (Alazawi et al.,
2002) or type 33 (Ruutu et al., 2002) contained viral ge-
nome in episomal form. Our studies have established that
blastemal cells are targets for MAV infection (Cherel et al.,
manuscript in preparation). Whether the accumulation of
linear MAV genomes in the cytoplasm of infected cells
(Bergman et al., 1980) is responsible for dysplasia of the
blastemal cells upon MAV infection remains to be established.
In conclusion, we have shown that several sequences
within the U3 region confer on MAV-1(N) its specific
tumorigenic potential. How these different regions cooper-
ate to dictate the high efficiency and the restricted specific-
ity of nephroblastoma induction is not known. It will be
interesting to determine whether these sequences that bind
transcription factors are specifically expressed in MAV tar-
get cells and to examine the expression level of these factors
in tumor samples.
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